...
首页> 外文期刊>Biochemistry and Biophysics Reports >Micro-RNAs and macrophage diversity in atherosclerosis: New players, new challenges…new opportunities for therapeutic intervention?
【24h】

Micro-RNAs and macrophage diversity in atherosclerosis: New players, new challenges…new opportunities for therapeutic intervention?

机译:动脉粥样硬化中的微小RNA和巨噬细胞多样性:新的参与者,新的挑战……治疗干预的新机会?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Efforts in experimental therapeutics of atherosclerosis are mostly focused on identifying candidate targets that can be exploited in developing new strategies to reduce plaque progression, induce its regression and/or improve stability of advanced lesions. Plaque macrophages are central players in all these processes, and consequently a significant amount of research is devoted to understanding mechanisms that regulate, for instance, macrophage apoptosis, necrosis or migration. Macrophage diversity is a key feature of the macrophage population in the plaque and can impact many aspects of lesion development. Thus, searching for molecular entities that contribute to atherorelevant functions of a specific macrophage type but not others may lead to identification of targets that can be exploited in phenotype selective modulation of the lesional macrophage. This however, remains an unmet goal. In recent years several studies have revealed critical functions of micro-RNAs (miRs) in mechanisms of macrophage polarization, and a number of miRs have emerged as being specific of distinctive macrophage subsets. Not only can these miRs represent the first step towards recognition of phenotype specific targets, but they may also pave the way to reveal novel atherorelevant pathways within macrophage subsets. This article discusses some of these recent findings, speculates on their potential relevance to atherosclerosis and elaborates on the prospective use of miRs to affect the function of plaque macrophages in a phenotype selective manner. Highlights ? Micro-RNAs are critical in macrophage polarization and atherosclerosis. ? Macrophage subsets have distinctive miRs. ? The use of miRs to target plaque macrophage subsets is discussed.
机译:动脉粥样硬化的实验疗法的努力主要集中于确定候选靶标,这些靶标可用于开发减少斑块进展,诱导其消退和/或改善晚期病变稳定性的新策略。噬菌斑巨噬细胞是所有这些过程的核心参与者,因此大量研究致力于理解调节例如巨噬细胞凋亡,坏死或迁移的机制。巨噬细胞多样性是斑块中巨噬细胞种群的关键特征,可影响病变发展的许多方面。因此,寻找有助于特定巨噬细胞类型的抗动脉粥样硬化功能而不是其他巨噬细胞类型的分子实体可以导致鉴定可用于病灶巨噬细胞的表型选择性调节中的靶标。但是,这仍然是未实现的目标。近年来,一些研究揭示了微RNA(miRs)在巨噬细胞极化机制中的关键功能,并且许多miR作为独特的巨噬细胞亚群而出现。这些miR不仅可以代表识别表型特异性靶标的第一步,而且还可以为揭示巨噬细胞亚群中新的抗动脉粥样硬化途径铺平道路。本文讨论了这些最新发现中的一些,推测了它们与动脉粥样硬化的潜在相关性,并阐述了miRs的潜在用途以表型选择性方式影响斑块巨噬细胞的功能。强调 ?微小RNA在巨噬细胞极化和动脉粥样硬化中至关重要。 ?巨噬细胞亚群具有独特的miR。 ?讨论了使用miR靶向噬菌斑巨噬细胞亚群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号